Nestle To Acquire Aimmune’s Allergy Treatment For $2 Billion

The Swiss company Nestle, which is better known for its foods products, is on a path to aggressively expand its fast-growing health science business and as a business strategy, the company has decided to pay $2 billion to gain full ownership of peanut allergy treatment maker Aimmune Therapeutics. Its health science subsidy called Nestle Health…